• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problem Excess Flow or Over-Infusion (1311)
Patient Problem Hypoglycemia (1912)
Event Date 06/09/2018
Event Type  Injury  
Event Description
Severe hypoglycaemia [hypoglycaemia].Novopen 4 over delivering the insulin dose that was delivered with the priming dose [incorrect dose administered by device].Case description: this serious spontaneous case from (b)(6) was reported by a diabetes nurse specialist as "severe hypoglycaemia" beginning on (b)(6) 2018, "novopen 4 over delivering the insulin dose that was delivered with the priming dose" beginning on (b)(6) 2018, and concerned a 9 years old male patient who was treated with novopen 4 (insulin delivery device) from unknown start date due to "type 1 diabetes mellitus".Patient's height: 146 cm; patient's weight: (b)(6); patient's bmi: 18.296.Medical history included type 1 diabetes mellitus (recent diagnosis entering honeymoon phase).Concommitant medication included - lantus junior star pen (non-codable), insulin.On an unknown date in 2018, the mother of the patient changed the cartridge into a novopen 4 and primed the pen and was surprised at the force of insulin that was delivered with the priming dose.The mother then dialled up the dose and administered.On (b)(6) 2018, the patient experienced severe hypoglycaemia requiring admission to hospital in an ambulance.It was presumed that, the hypoglycaemia was due to the pen over delivering an insulin dose.The patient was discharged in (b)(6) 2018.Information on batch number was not provided.Action taken to novopen 4 was product discontinued.On (b)(6) 2018 the outcome for the event "severe hypoglycaemia" was recovered with sequelae.The outcome for the event "novopen 4 over delivering the insulin dose that was delivered with the priming dose" was not reported.Investigation result: product: novopen 4; batch number: unknown.No investigation was possible, because neither sample nor batch number was available.Manufacturer's comment: on 24-jul-2018: as the device novopen 4 has not been returned to novo nordisk a/s for investigation and only very limited information regarding the handling of suspected device is available, it is not possible to identify a clear root-cause of the experienced adverse event and thus find similar incidents to the one reported in argus case (b)(4).Evaluation summary: investigation result; product: novopen 4, batch number: unknown.No investigation was possible, because neither sample nor batch number was available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 4
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S, MEDICAL SYSTEMS
hilleroed,
DA 
Manufacturer (Section G)
NOVO NORDISK A/S, MEDICAL SYSTEMS
brennum park
hilleroed, 3400
DA   3400
Manufacturer Contact
p.o. box 846
plainsboro, NJ 08536
8007276500
MDR Report Key7722653
MDR Text Key115115833
Report Number9681821-2018-00052
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
20-986
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/26/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberN/A
Device Catalogue Number185490
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/05/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
INSULIN (INSULIN) SOLUTION FOR INJECTION
Patient Outcome(s) Hospitalization;
Patient Age9 YR
Patient Weight39
-
-